Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019.
Danpanichkul P, Suparan K, Dutta P, Kaeosri C, Sukphutanan B, Pang Y, Kulthamrongsri N, Jaisa-Aad M, Ng CH, Teng M, Nakano M, Morishita A, Alkhouri N, Yang JD, Chen VL, Kim D, Fallon MB, Diaz LA, Arab JP, Mantzoros CS, Noureddin M, Lazarus JV, Wijarnpreecha K. Danpanichkul P, et al. Among authors: morishita a. Metabolism. 2024 Sep;158:155958. doi: 10.1016/j.metabol.2024.155958. Epub 2024 Jun 26. Metabolism. 2024. PMID: 38942169
Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-Analysis.
Tham EKJ, Lim RY, Koh B, Tan DJH, Ng CH, Law M, Cho E, Tang NSY, Tan CS, Sim BKL, Tan EY, Lim WH, Lim MC, Nakamura T, Danpanichkul P, Chirapongsathorn S, Wijarnpreecha K, Takahashi H, Morishita A, Zheng MH, Kow A, Muthiah M, Law JH, Huang DQ. Tham EKJ, et al. Among authors: morishita a. Clin Gastroenterol Hepatol. 2024 Oct 24:S1542-3565(24)00971-6. doi: 10.1016/j.cgh.2024.09.028. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39461458 Review.
Liver cancer in 2021: Global burden of disease study.
Tan EY, Danpanichkul P, Yong JN, Yu Z, Tan DJH, Lim WH, Koh B, Lim RYZ, Tham EKJ, Mitra K, Morishita A, Hsu YC, Yang JD, Takahashi H, Zheng MH, Nakajima A, Ng CH, Wijarnpreecha K, Muthiah MD, Singal AG, Huang DQ. Tan EY, et al. Among authors: morishita a. J Hepatol. 2024 Oct 30:S0168-8278(24)02652-7. doi: 10.1016/j.jhep.2024.10.031. Online ahead of print. J Hepatol. 2024. PMID: 39481652
Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic Review.
Cho EEL, Law M, Yu Z, Yong JN, Tan CS, Tan EY, Takahashi H, Danpanichkul P, Nah B, Soon GST, Ng CH, Tan DJH, Seko Y, Nakamura T, Morishita A, Chirapongsathorn S, Kumar R, Kow AWC, Huang DQ, Lim MC, Law JH. Cho EEL, et al. Among authors: morishita a. Dig Dis Sci. 2024 Dec 21. doi: 10.1007/s10620-024-08747-5. Online ahead of print. Dig Dis Sci. 2024. PMID: 39708260
Efficacy of imeglimin in patients with type 2 diabetes mellitus complicated by metabolic dysfunction-associated steatotic liver disease: A multicentre study.
Fukunaga K, Morishita A, Imachi H, Oura K, Sato S, Kobayashi T, Saheki T, Yoshimura T, Komori K, Nakahara M, Tadokoro T, Fujita K, Tani J, Kobara H, Murao K. Fukunaga K, et al. Among authors: morishita a. Diabetes Obes Metab. 2024 Dec 26. doi: 10.1111/dom.16157. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39726210
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study.
Iwaki M, Fujii H, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Tsutsumi T, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T. Iwaki M, et al. Among authors: morishita a. Clin Mol Hepatol. 2024 Apr;30(2):225-234. doi: 10.3350/cmh.2023.0515. Epub 2024 Jan 24. Clin Mol Hepatol. 2024. PMID: 38263684 Free PMC article.
Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction-associated steatotic liver disease: A prospective, multicentre, observational study.
Arai T, Atsukawa M, Tsubota A, Oikawa T, Tada T, Matsuura K, Ishikawa T, Abe H, Kato K, Morishita A, Tani J, Okubo T, Nagao M, Iwabu M, Iwakiri K. Arai T, et al. Among authors: morishita a. Diabetes Obes Metab. 2024 Nov;26(11):4958-4965. doi: 10.1111/dom.15898. Epub 2024 Sep 2. Diabetes Obes Metab. 2024. PMID: 39223865
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease.
Ishiba H, Fujii H, Kamada Y, Sumida Y, Takahashi H, Seko Y, Toyoda H, Hayashi H, Yamaguchi K, Iwaki M, Yoneda M, Arai T, Shima T, Morishita A, Kawata K, Tomita K, Kawanaka M, Yoshida Y, Ikegami T, Notsumata K, Oeda S, Fukushima H, Miyoshi E, Aishima S, Itoh Y, Okanoue T, Nakajima A; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Ishiba H, et al. Among authors: morishita a. Hepatol Commun. 2024 Dec 11;9(1):e0563. doi: 10.1097/HC9.0000000000000563. eCollection 2025 Jan 1. Hepatol Commun. 2024. PMID: 39670882 Free PMC article.
Submucosal tunneling techniques: current perspectives.
Kobara H, Mori H, Rafiq K, Fujihara S, Nishiyama N, Ayaki M, Yachida T, Matsunaga T, Tani J, Miyoshi H, Yoneyama H, Morishita A, Oryu M, Iwama H, Masaki T. Kobara H, et al. Among authors: morishita a. Clin Exp Gastroenterol. 2014 Apr 5;7:67-74. doi: 10.2147/CEG.S43139. eCollection 2014. Clin Exp Gastroenterol. 2014. PMID: 24741323 Free PMC article. Review.
424 results